Exclusive

Publication

Byline

Location

US Patent Issued to Shanghai Hui Tian Jin Ze Biotech on April 14 for "Anti-tumor pharmaceutical composition based on immune checkpoint blockade and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,596, issued on April 14, was assigned to Shanghai Hui Tian Jin Ze Biotech Co. Ltd. (Shanghai). "Anti-tumor pharmaceutical composition base... Read More


US Patent Issued to AUSPEX PHARMACEUTICALS on April 14 for "Osmotic dosage forms comprising deutetrabenazine and methods of use thereof" (Florida, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,598, issued on April 14, was assigned to AUSPEX PHARMACEUTICALS LLC (Parsippany, N.J.). "Osmotic dosage forms comprising deutetrabenazine ... Read More


US Patent Issued to Arizona Board of Regents on Behalf of the University of Arizona, University of Washington on April 14 for "Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity" (Arizona, Washington Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,600, issued on April 14, was assigned to Arizona Board of Regents on Behalf of the University of Arizona (Tucson, Ariz.) and University of ... Read More


US Patent Issued to Mirum Pharmaceuticals on April 14 for "Methods for treating cholestasis" (American, Swiss Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,602, issued on April 14, was assigned to Mirum Pharmaceuticals Inc.. "Methods for treating cholestasis" was invented by Thomas Jaecklin (D... Read More


US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS on April 14 for "Application of JAK inhibitor in kidney disease" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,604, issued on April 14, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China). "Application of JAK inhibitor in k... Read More


US Patent Issued to Janssen Biotech, Yuhan on April 14 for "Therapies with 3rd generation EGFR tyrosine kinase inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,606, issued on April 14, was assigned to Janssen Biotech Inc. (Horsham, Pa.) and Yuhan Corp. (Seoul, South Korea). "Therapies with 3rd gen... Read More


US Patent Issued to The Regents of the University of California, The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Gladstone on April 14 for "Methods for treating cardiac valve disease" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,608, issued on April 14, was assigned to The Regents of the University of California (Oakland, Calif.) and The J. David Gladstone Institute... Read More


US Patent Issued to Merck Sharp & Dohme on April 14 for "Solid dosage formulations of an orexin receptor antagonist" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,610, issued on April 14, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Solid dosage formulations of an orexin receptor antagoni... Read More


US Patent Issued to Lucolas-M.D. on April 14 for "Pharmaceutical use" (French Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,612, issued on April 14, was assigned to Lucolas-M.D. Ltd. (Birmingham, Great Britain). "Pharmaceutical use" was invented by Alfred Schmid... Read More


US Patent Issued to MD VAULT on April 14 for "Methods and pharmaceutical compositions for the treatment and prophylaxis of microbial infectious diseases and associated inflammatory disorders and for the treatment and prophylaxis of aging and associated diseases" (Delaware Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,614, issued on April 14, was assigned to MD VAULT LLC (Lewes, Del.). "Methods and pharmaceutical compositions for the treatment and prophy... Read More